0001655759-24-000033.txt : 20240318 0001655759-24-000033.hdr.sgml : 20240318 20240318164512 ACCESSION NUMBER: 0001655759-24-000033 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240314 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240318 DATE AS OF CHANGE: 20240318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARVINAS, INC. CENTRAL INDEX KEY: 0001655759 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472566120 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38672 FILM NUMBER: 24759708 BUSINESS ADDRESS: STREET 1: 395 WINCHESTER AVE STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-535-1456 MAIL ADDRESS: STREET 1: 395 WINCHESTER AVE STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 FORMER COMPANY: FORMER CONFORMED NAME: ARVINAS INC. DATE OF NAME CHANGE: 20181001 FORMER COMPANY: FORMER CONFORMED NAME: ARVINAS HOLDING COMPANY, LLC DATE OF NAME CHANGE: 20151015 8-K 1 arvn-20240314.htm 8-K arvn-20240314
0001655759FALSE00016557592024-03-142024-03-14

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________________
FORM 8-K
__________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 14, 2024
__________________
Arvinas, Inc.
(Exact name of registrant as specified in its charter)
__________________
Delaware001-3867247-2566120
(State or other jurisdiction
of incorporation)		(Commission
File Number)		(IRS Employer
Identification No.)
5 Science Park
395 Winchester Ave.
New Haven, Connecticut
06511
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (203) 535-1456
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
__________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Common stock, par value $0.001 per shareARVN
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 18, 2024, Arvinas, Inc., a Delaware corporation (the “Company”), announced the appointment of Noah Berkowitz, M.D., Ph.D., to the role of chief medical officer, effective as of March 18, 2024. Dr. Berkowitz will lead the ongoing clinical development of the Company’s PROTAC® protein degrader programs in oncology and neuroscience.
Dr. Berkowitz has more than 20 years of experience in advancing programs through early and late stages of development, including experience in clinical development, regulatory, and medical affairs. Dr. Berkowitz most recently served as Senior Vice President, Development Unit Head, Hematology, at Bristol-Myers Squibb, a global biopharmaceutical company.
On March 14, 2024, the Company notified Ron Peck, M.D., the Company’s previously serving chief medical officer, of Dr. Berkowitz’s pending appointment and the reassignment of the responsibilities of chief medical officer to Dr. Berkowitz effective as of March 18, 2024. The Company anticipates that Dr. Peck will continue as an employee of the Company until mid-April 2024 for a transition period before leaving to pursue other opportunities. Subject to execution and nonrevocation of a release of claims in the Company’s favor and his continued compliance with his proprietary rights, non-disclosure, developments, non-competition and non-solicitation agreement, Dr. Peck will be entitled to the severance benefits provided under his employment agreement in connection with a termination of his employment without cause or for good reason. These severance benefits include, subject to the terms of his employment agreement, (1) continued payment of his base salary for a period of nine months and (2) payment of the portion of health coverage premiums paid for similarly-situated, active employees who receive the same type of coverage, for a period of up to nine months.
Item 9.01
Financial Statements and Exhibits.
(d)Exhibits

Exhibit NumberDescription of Exhibit
104Cover Page Interactive Data File (formatted as Inline XBRL)


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ARVINAS, INC.
Date: March 18, 2024By:/s/ Randy Teel
Randy Teel
Interim Chief Financial Officer

 EX-101.SCH 2 arvn-20240314.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 arvn-20240314_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Address, Address Line Two Entity Address, Address Line Two Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications City Area Code City Area Code Cover [Abstract] Title of 12(b) Security Title of 12(b) Security Document Type Document Type Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 4 arvn-20240314_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover
Mar. 14, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Mar. 14, 2024
Entity Registrant Name Arvinas, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-38672
Entity Tax Identification Number 47-2566120
Entity Address, Address Line One 5 Science Park
Entity Address, Address Line Two 395 Winchester Ave.
Entity Address, City or Town New Haven
Entity Address, State or Province CT
Entity Address, Postal Zip Code 06511
City Area Code 203
Local Phone Number 535-1456
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, par value $0.001 per share
Trading Symbol ARVN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001655759
Amendment Flag false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://www.arvinas.com/role/Cover Cover Cover 1 false false All Reports Book All Reports arvn-20240314.htm arvn-20240314.xsd arvn-20240314_lab.xml arvn-20240314_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "arvn-20240314.htm": { "nsprefix": "arvn", "nsuri": "http://www.arvinas.com/20240314", "dts": { "inline": { "local": [ "arvn-20240314.htm" ] }, "schema": { "local": [ "arvn-20240314.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] }, "labelLink": { "local": [ "arvn-20240314_lab.xml" ] }, "presentationLink": { "local": [ "arvn-20240314_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2022": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 25, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "report": { "R1": { "role": "http://www.arvinas.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "arvn-20240314.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "arvn-20240314.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AmendmentFlag", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CityAreaCode", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentType", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityFileNumber", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityRegistrantName", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "LocalPhoneNumber", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "Security12bTitle", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SecurityExchangeName", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SolicitingMaterial", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "TradingSymbol", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "WrittenCommunications", "presentation": [ "http://www.arvinas.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0001655759-24-000033-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001655759-24-000033-xbrl.zip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�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arvn-20240314_htm.xml IDEA: XBRL DOCUMENT 0001655759 2024-03-14 2024-03-14 0001655759 false 8-K 2024-03-14 Arvinas, Inc. DE 001-38672 47-2566120 5 Science Park 395 Winchester Ave. New Haven CT 06511 203 535-1456 false false false false Common stock, par value $0.001 per share ARVN NASDAQ false